Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucil-Reference-Cited by-同舟云学术

Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucil

Author:

Tam Constantine¹²,Kuss Bryone³,Opat Stephen⁴,Boulos Joy⁵,Marlton Paula⁶⁷

Affiliation:

1. Department of Haematology; St Vincent's Hospital; Melbourne Victoria Australia

2. Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Victoria Australia

3. Department of Haematology; Flinders University and Flinders Medical Centre; Adelaide South Australia Australia

4. Department of Haematology; Monash Medical Centre and Monash University; Melbourne Victoria Australia

5. Roche Products Limited; Sydney New South Wales Australia

6. Department of Haematology; Princess Alexandra Hospital; Brisbane Queensland Australia

7. University of Queensland School of Medicine; Brisbane Queensland Australia

Funder

Roche Products Pty Ltd.

Publisher

Wiley

Subject

Internal Medicine

Link

Reference21 articles.

1. Chronic lymphocytic leukaemia;Kipps;Nat Rev Dis Primers,2017

4. National Comprehensive Cancer Network 2017 https://www.nccn.org

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

;Drug Design, Development and Therapy;2019-08